Egfr Epidermal Growth Factor Receptor is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Epidermal Growth Factor Receptor | |
|---|---|
| Gene Symbol | EGFR |
| Full Name | Epidermal Growth Factor Receptor |
| Chromosome | 7p11.2 |
| NCBI Gene ID | 1956 |
| OMIM | 131550 |
| Ensembl ID | ENSG00000146648 |
| UniProt ID | P00533 |
| Associated Diseases | Alzheimer's Disease, Lung Cancer, Glioblastoma, Inflammatory disorders |
EGFR is a gene that encodes a protein involved in epidermal growth factor receptor signaling and cell proliferation. This gene is implicated in neurodegenerative diseases and represents a potential therapeutic target.
EGFR is a receptor tyrosine kinase that binds EGF and other growth factors. It activates multiple signaling pathways including MAPK, PI3K/AKT, and JAK/STAT. EGFR is critical for cell growth, survival, and differentiation[^1].
EGFR is one of four ErbB receptors:
EGFR performs essential functions:
EGFR implicated in AD:
EGFR mutated/amplified in:
EGFR is expressed in:
Yarden Y, Sliwkowski MX. (2001). "ErbB signaling." Nat Rev Mol Cell Biol. 2(2):127-137.[^1]
Zhang Y, et al. (2017). "EGFR in AD." Neurobiol Aging. 57:28-35.[^2]
The study of Egfr Epidermal Growth Factor Receptor has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.